A case study of nephrologists examines physicians' attitudes towards patients in advanced stages of kidney disease and how these attitudes affect the end-of-life care the patient receives.
New guidelines and the continuous modification of current policies will be needed in order to establish and maintain an appropriate professional relationship between physicians and pharmaceutical companies.